Strides gets Pfizer another approval under US oncodrug pact
This article was originally published in Scrip
Strides Arcolab has received FDA approval for its ANDA for the chemotherapy drug, topotecan hydrochloride injection, adding to the list of such clearances for oncology products that have been licensed to Pfizer for the US market.
You may also be interested in...
Years after a scathing Indian parliamentary report flagged concerns around regulatory lapses for drug approvals, an expert panel has endorsed the continued marketing of ambrisentan and everolimus in the country. But dronedarone, also featured in the report, is no longer sold by Sanofi in India.
Tecentriq cleared for extensive-stage small cell lung cancer in India but pricing remains a key constraining factor. Patient assistance schemes help but such novel therapies still unaffordable to a vast majority.